Senores Pharmaceuticals IPO (Senores Pharmaceuticals Limited IPO)
Senores Pharmaceuticals IPO Pulse
IPO Pulse Score of Senores Pharmaceuticals IPO is 70%
Interpretation of IPO Pulse Score
- Score above 80%: Strongly recommend to apply.
- Score between 60% to 80%: Moderately recommend, consider other qualitative factors.
- Score below 60%: Caution, recommend detailed analysis before applying.
Check IPO Pulse Score Past Performance
The IPO Pulse Score is a comprehensive measure designed to evaluate the attractiveness and potential of an Initial Public Offering (IPO). This score is derived from a detailed analysis of various key factors that are critical to the success of an IPO such as Revenue Growth, Profitability, Debt Levels, Return Ratios, Valuation Metrics, Market Share, Use of IPO Proceeds, Market Sentiment, Industry Growth, Competitive Advantage, Management Experience, Corporate Governance etc.
Disclaimer:
The IPO Pulse Score is intended solely for informational purposes. The score is derived from a combination of quantitative and qualitative factors that are subject to change. While we strive to provide accurate and up-to-date information, Investors are advised to conduct their own thorough research and consult with financial advisors before making any investment decisions. The IPO Pulse Score should not be the sole basis for any investment decision.
Senores Pharmaceuticals IPO Peers Comparison
Senores Pharmaceuticals IPO Comparison with Similar Listed Entities. Data as of 31st March 2024.
| Name | Revenue from Operations (₹ Cr) | RoNW | P/E Ratio | PAT Margin |
|---|---|---|---|---|
| Senores Pharmaceuticals Limited | 214.52 | 23.60% | 39.77 | 15.25% |
| Ajanta Pharma Limited | 4,208.71 | 23.47% | 43.34 | 19.39% |
| Alembic Pharmaceuticals Limited | 6,228.63 | 13.40% | 33.90 | 9.89% |
| Caplin Point Laboratories Limited | 1,694.10 | 21.69% | 40.84 | 27.24% |
| Gland Pharma Limited | 5,664.72 | 9.26% | 37.27 | 13.64% |
| Strides Pharma Science Limited | 4,051.12 | -4.44% | -2.33% |
